Top 5 FDA-Approved Medications for Breast Cancer Treatment

Discover the five FDA-approved medications for breast cancer, including their functions and uses. These targeted drugs help manage different forms of breast cancer, offering hope for effective treatment. Consult your doctor for personalized advice, early detection, and tailored therapy options to improve outcomes and reduce recurrence risks. Stay informed about the latest advancements in breast cancer management to enhance your treatment journey.

Breast cancer remains the second most common cancer among women globally, primarily affecting women, though men can also develop it. It originates in the breast cells, with causes often linked to genetics and environmental influences. Early detection through mammograms and physical exams is crucial, especially when symptoms like lumps, skin changes, nipple inversion, or skin peeling are noticed. Treatments often involve targeted medications, which include:

Afinitor®
Known as Afinitor Disperz, this drug inhibits cancer cell growth, slowing disease progression. It’s also used for certain kidney and brain tumors, and some pancreatic and gastrointestinal tumors, as well as specific brain and kidney tumors in tuberous sclerosis.

Piqray®
Also called Alpelisib, Piqray inhibits the PI3K pathway, starving cancer cells of energy and helping to treat hormone-receptor-positive, HER2-negative metastatic breast cancer with PIK3CA mutations in postmenopausal women and men.

Nerlynx®
Featuring neratinib, this medication is approved for early-stage HER2-positive breast cancer post-surgery. It reduces recurrence by blocking tumor growth, especially in women previously treated with trastuzumab.

Kisqali®
Known as ribociclib, Kisqali targets cell growth proteins and is used in combination with hormone therapy for advanced hormone receptor-positive, HER2-negative breast cancer in postmenopausal women without prior drug treatment.

Ibrance®
Also called palbociclib, Ibrance is prescribed for metastatic ER-positive, HER2-negative breast cancer, particularly in postmenopausal women, by inhibiting enzymes essential for cancer cell proliferation.

Note: Always consult a healthcare professional for medical advice; this article is for informational purposes only.